Shots: Ambrx to receive up front, development milestones and royalties on sales of ARX305 in China and retain rights to develop & commercialize ARX305 outside China. NovoCodex to get right […]readmore
Tags : Ambrx
Shots: Ambrx will receive $475M as a total deal value including $29M upfront for research & other programs, $446M as development, regulatory & commercial milestones and royalties on global sales. […]readmore